Pralidoxime Chloride NEW
| Price | $30 | $65 |
| Package | 100mg | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Pralidoxime Chloride | CAS No.: 51-15-0 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Pralidoxime Chloride |
| Description | Pralidoxime Chloride (2-PAM chloride) is a useful agent in the treatment of organophosphate poisoning. Pralidoxime binds to organophosphate-inactivated acetylcholinesterase, used to combat poisoning by organophosphates or acetylcholinesterase inhibitors (nerve agents). |
| In vitro | The application of pralidoxime allowed the regeneration of an important fraction of inhibited AChE, process which is concentration-dependent[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (11.59 mM), Sonication is recommended. DMSO : 50 mg/mL (289.67 mM), Sonication and heating are recommended. |
| Keywords | reactivator | Pralidoxime Chloride | Pralidoxime | plethymosgraphy | organophosphorus | organophosphates | nerve agent | Inhibitor | inhibit | diethylparaoxon | Cholinesterase (ChE) | AchE | 2-PAM Chloride | 2-PAM |
| Inhibitors Related | Uridine 5'-monophosphate disodium salt | Ethyl (triphenylphosphoranylidene) acetate | Methylene Violet 3RAX | 4-Methylbenzylidene camphor | (±)-Dihydroactinidiolide | Diethyltoluamide | Pralidoxime Iodide | Propoxur | Dimethyl sulfoxide | Coumaran | Methyl tridecanoate | Trimethylammonium chloride |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Alzheimer's Disease Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Drug-Fragment Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2026-07-13 | |
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-13 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $65.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $1.10 |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-06-25 | |
| $150.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2025-05-23 | ||
|
Henan Suikang Pharmaceutical Co.,Ltd.
|
2025-04-15 | |||
| $30.00 |
Anhui Ruihan Technology Co., Ltd
|
2023-09-08 | ||
| $10.00 |
Hebei Zhanyao Biotechnology Co. Ltd
|
2022-01-18 | ||
| $1.20 |
Qiuxian Baitai New Material Co., LTD
|
2021-11-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY